PubRank

Arati Sharma

Author PubWeight™ 28.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 2004 3.80
2 Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development. Cancer Res 2008 2.18
3 eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cancer Res 2011 2.10
4 Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res 2005 1.60
5 Loss of PTEN promotes tumor development in malignant melanoma. Cancer Res 2003 1.58
6 Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res 2010 1.55
7 PRAS40 deregulates apoptosis in malignant melanoma. Cancer Res 2007 1.52
8 Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development. Cancer Res 2008 1.51
9 Targeting mutant (V600E) B-Raf in melanoma interrupts immunoediting of leukocyte functions and melanoma extravasation. Cancer Res 2007 1.31
10 Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasms. J Invest Dermatol 2004 1.13
11 Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis. Mol Ther 2013 1.12
12 Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Lett 2008 1.12
13 Robust activation of the human but not mouse telomerase gene during the induction of pluripotency. FASEB J 2010 1.07
14 Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates. J Med Chem 2008 0.99
15 PBISe, a novel selenium-containing drug for the treatment of malignant melanoma. Mol Cancer Ther 2008 0.94
16 Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns. Cancer Res 2012 0.94
17 Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4. Cancer Prev Res (Phila) 2010 0.93
18 Propagation of undifferentiated human embryonic stem cells with nano-liposomal ceramide. Stem Cells Dev 2010 0.92
19 Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma. Pigment Cell Melanoma Res 2013 0.91
20 Macrophage inhibitory cytokine-1 regulates melanoma vascular development. Am J Pathol 2010 0.91
21 Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe)--against colon cancer. Bioorg Med Chem Lett 2009 0.86